Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 612

1.

Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study.

Sadlonova M, Meyer T, Binder L, Wachter R, Edelmann F, Herrmann-Lingen C.

Psychoneuroendocrinology. 2018 Dec 20;101:272-277. doi: 10.1016/j.psyneuen.2018.12.230. [Epub ahead of print]

PMID:
30594111
2.

Development and validation of a score to detect paroxysmal atrial fibrillation after stroke.

Uphaus T, Weber-Krüger M, Grond M, Toenges G, Jahn-Eimermacher A, Jauss M, Kirchhof P, Wachter R, Gröschel K.

Neurology. 2019 Jan 8;92(2):e115-e124. doi: 10.1212/WNL.0000000000006727. Epub 2018 Dec 7.

PMID:
30530796
3.

Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018.

Rosenkranz S, Lang IM, Blindt R, Bonderman D, Bruch L, Diller GP, Felgendreher R, Gerges C, Hohenforst-Schmidt W, Holt S, Jung C, Kindermann I, Kramer T, Kübler WM, Mitrovic V, Riedel A, Rieth A, Schmeisser A, Wachter R, Weil J, Opitz CF.

Int J Cardiol. 2018 Dec 1;272S:53-62. doi: 10.1016/j.ijcard.2018.08.080. Epub 2018 Aug 27.

PMID:
30527996
4.

Assembly-disassembly is coupled to the ATPase cycle of tobacco Rubisco activase.

Serban AJ, Breen IL, Bui HQ, Levitus M, Wachter RM.

J Biol Chem. 2018 Dec 14;293(50):19451-19465. doi: 10.1074/jbc.RA118.005047. Epub 2018 Oct 23.

PMID:
30352875
5.

Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension.

Wallbach M, Zürbig P, Dihazi H, Müller GA, Wachter R, Beige J, Koziolek MJ, Mischak H.

J Clin Hypertens (Greenwich). 2018 Oct;20(10):1519-1526. doi: 10.1111/jch.13365. Epub 2018 Sep 10.

6.

[Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].

Wallbach M, Koziolek MJ, Wachter R.

Internist (Berl). 2018 Oct;59(10):1011-1020. doi: 10.1007/s00108-018-0488-0. Review. German.

PMID:
30182192
7.

A tribute to Lloyd Hollingsworth "Holly" Smith Jr. (1924-2018).

Wachter RM, King TE Jr.

J Clin Invest. 2018 Aug 31;128(9):3649-3650. doi: 10.1172/JCI123460. Epub 2018 Aug 6. No abstract available.

8.

Transforming concepts in patient safety: a progress report.

Gandhi TK, Kaplan GS, Leape L, Berwick DM, Edgman-Levitan S, Edmondson A, Meyer GS, Michaels D, Morath JM, Vincent C, Wachter R.

BMJ Qual Saf. 2018 Dec;27(12):1019-1026. doi: 10.1136/bmjqs-2017-007756. Epub 2018 Jul 17.

9.

Associations of NT-proBNP and parameters of mental health in depressed coronary artery disease patients.

Fangauf SV, Herbeck Belnap B, Meyer T, Albus C, Binder L, Deter HC, Ladwig KH, Michal M, Ronel J, Rothenberger A, Söllner W, Wachter R, Weber CS, Herrmann-Lingen C; SPIRR-CAD study group.

Psychoneuroendocrinology. 2018 Oct;96:188-194. doi: 10.1016/j.psyneuen.2018.06.001. Epub 2018 Jun 4.

PMID:
29982099
10.

Two Randomised Clinical Trials on the Use of Bryophyllum pinnatum in Preterm Labour: Results after Early Discontinuation.

Simões-Wüst AP, Lapaire O, Hösli I, Wächter R, Fürer K, Schnelle M, Mennet-von Eiff M, Seifert B, von Mandach U.

Complement Med Res. 2018;25(4):269-273. doi: 10.1159/000487431. Epub 2018 Jun 22. No abstract available.

PMID:
29945146
11.

Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).

Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, Edelmann F, Filippatos G, Gruson D, Ikonomidis I, Lhommel R, Mahmod M, Neubauer S, Persu A, Gerber BL, Piechnik S, Pieske B, Pieske-Kraigher E, Pinto F, Ponikowski P, Senni M, Trochu JN, Van Overstraeten N, Wachter R, Balligand JL.

ESC Heart Fail. 2018 Oct;5(5):830-841. doi: 10.1002/ehf2.12306. Epub 2018 Jun 22. Erratum in: ESC Heart Fail. 2018 Dec;5(6):1199.

12.

Resolving the Productivity Paradox of Health Information Technology: A Time for Optimism.

Wachter RM, Howell MD.

JAMA. 2018 Jul 3;320(1):25-26. doi: 10.1001/jama.2018.5605. No abstract available.

PMID:
29813165
13.

Cross-Sectional and Longitudinal Associations of Systolic Blood Pressure With Quality of Life and Depressive Mood in Older Adults With Cardiovascular Risk Factors: Results From the Observational DIAST-CHF Study.

Herrmann-Lingen C, Meyer T, Bosbach A, Chavanon ML, Hassoun L, Edelmann F, Wachter R.

Psychosom Med. 2018 Jun;80(5):468-474. doi: 10.1097/PSY.0000000000000591.

PMID:
29742752
14.

Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.

Ravassa S, Trippel T, Bach D, Bachran D, González A, López B, Wachter R, Hasenfuss G, Delles C, Dominiczak AF, Pieske B, Díez J, Edelmann F.

Eur J Heart Fail. 2018 Sep;20(9):1290-1299. doi: 10.1002/ejhf.1194. Epub 2018 Apr 30.

PMID:
29709099
15.

Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.

Siller-Matula JM, Pecen L, Patti G, Lucerna M, Kirchhof P, Lesiak M, Huber K, Verheugt FWA, Lang IM, Renda G, Schnabel RB, Wachter R, Kotecha D, Sellal JM, Rohla M, Ricci F, De Caterina R; TEAM in AF group.

Int J Cardiol. 2018 Aug 15;265:141-147. doi: 10.1016/j.ijcard.2018.04.093. Epub 2018 Apr 22.

PMID:
29706429
16.

Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.

Halbach M, Abraham WT, Butter C, Ducharme A, Klug D, Little WC, Reuter H, Schafer JE, Senni M, Swarup V, Wachter R, Weaver FA, Wilks SJ, Zile MR, Müller-Ehmsen J.

Int J Cardiol. 2018 Sep 1;266:187-192. doi: 10.1016/j.ijcard.2018.04.075. Epub 2018 Apr 21.

PMID:
29705650
17.

Expert opinion paper on atrial fibrillation detection after ischemic stroke.

Haeusler KG, Gröschel K, Köhrmann M, Anker SD, Brachmann J, Böhm M, Diener HC, Doehner W, Endres M, Gerloff C, Huttner HB, Kaps M, Kirchhof P, Nabavi DG, Nolte CH, Pfeilschifter W, Pieske B, Poli S, Schäbitz WR, Thomalla G, Veltkamp R, Steiner T, Laufs U, Röther J, Wachter R, Schnabel R.

Clin Res Cardiol. 2018 Oct;107(10):871-880. doi: 10.1007/s00392-018-1256-9. Epub 2018 Apr 27. Review.

PMID:
29704214
18.

Safety profile of baroreflex activation therapy (NEO) in patients with resistant hypertension.

Wallbach M, Böhning E, Lehnig LY, Schroer C, Müller GA, Wachter R, Lüders S, Zenker D, Koziolek MJ.

J Hypertens. 2018 Aug;36(8):1762-1769. doi: 10.1097/HJH.0000000000001753.

PMID:
29677053
19.

Relationship between exercise intervention and NO pathway in patients with heart failure with preserved ejection fraction.

Baldassarri F, Schwedhelm E, Atzler D, Böger RH, Cordts K, Haller B, Pressler A, Müller S, Suchy C, Wachter R, Düngen HD, Hasenfuss G, Pieske B, Halle M, Edelmann F, Duvinage A.

Biomarkers. 2018 Sep;23(6):540-550. doi: 10.1080/1354750X.2018.1460762. Epub 2018 Apr 12.

PMID:
29619838
20.

Single-molecule diffusometry reveals the nucleotide-dependent oligomerization pathways of Nicotiana tabacum Rubisco activase.

Wang Q, Serban AJ, Wachter RM, Moerner WE.

J Chem Phys. 2018 Mar 28;148(12):123319. doi: 10.1063/1.5005930.

PMID:
29604852
21.

[Atrial fibrillation as a comorbidity of heart failure].

Wachter R.

Internist (Berl). 2018 May;59(5):415-419. doi: 10.1007/s00108-018-0411-8. Review. German.

PMID:
29600336
22.

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.

Hellenkamp K, Pruszczyk P, Jiménez D, Wyzgał A, Barrios D, Ciurzyński M, Morillo R, Hobohm L, Keller K, Kurnicka K, Kostrubiec M, Wachter R, Hasenfuß G, Konstantinides S, Lankeit M.

Eur Respir J. 2018 Apr 19;51(4). pii: 1702037. doi: 10.1183/13993003.02037-2017. Print 2018 Apr.

PMID:
29599188
23.

[Acute treatment and secondary prophylaxis of ischemic stroke : An excellent example for personalized medicine].

Wachter R, Gröschel K.

Internist (Berl). 2018 Mar;59(3):241-251. doi: 10.1007/s00108-018-0382-9. German.

PMID:
29459990
24.

Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in Germany.

Wachter R, Viriato D, Klebs S, Grunow SS, Schindler M, Engelhard J, Proenca CC, Calado F, Schlienger R, Dworak M, Balas B, Bruce Wirta S.

Postgrad Med. 2018 Apr;130(3):308-316. doi: 10.1080/00325481.2018.1442090. Epub 2018 Feb 28.

PMID:
29446691
25.

RAF2 is a RuBisCO assembly factor in Arabidopsis thaliana.

Fristedt R, Hu C, Wheatley N, Roy LM, Wachter RM, Savage L, Harbinson J, Kramer DM, Merchant SS, Yeates T, Croce R.

Plant J. 2018 Apr;94(1):146-156. doi: 10.1111/tpj.13849. Epub 2018 Mar 12.

PMID:
29396988
26.

Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study.

Conti S, Reiffel JA, Gersh BJ, Kowey PR, Wachter R, Halperin JL, Kaplon RE, Pouliot E, Verma A.

J Atr Fibrillation. 2017 Feb 28;9(5):1551. doi: 10.4022/jafib.1551. eCollection 2017 Feb-Mar.

27.

Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.

Patel H, Fang MC, Mourad M, Green A, Wachter RM, Murphy RD, Harrison JD.

J Hosp Med. 2018 Jun 1;13(6):388-391. doi: 10.12788/jhm.2885. Epub 2017 Dec 6.

PMID:
29240850
28.

Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan.

Pascual-Figal D, Wachter R, Senni M, Belohlavek J, Noè A, Carr D, Butylin D.

ESC Heart Fail. 2018 Apr;5(2):327-336. doi: 10.1002/ehf2.12246. Epub 2017 Dec 14.

29.

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction.

Bobenko A, Bartels I, Münch M, Trippel T, Lindhorst R, Nolte K, Herrmann-Lingen C, Halle M, Duvinage A, Düngen HD, Gelbrich G, Tschöpe C, Hasenfuss G, Wachter R, Pieske B, Edelmann F.

ESC Heart Fail. 2018 Feb;5(1):53-62. doi: 10.1002/ehf2.12227. Epub 2017 Dec 6.

30.

Pragmatic Insights on Patient Safety Priorities and Intervention Strategies in Ambulatory Settings.

Sarkar U, McDonald K, Motala A, Smith P, Zipperer L, Wachter RM, Shanman R, Shekelle PG.

Jt Comm J Qual Patient Saf. 2017 Dec;43(12):661-670. doi: 10.1016/j.jcjq.2017.06.009. No abstract available.

PMID:
29173287
31.

Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study.

Senni M, McMurray JJV, Wachter R, McIntyre HF, Anand IS, Duino V, Sarkar A, Shi V, Charney A.

Eur J Heart Fail. 2018 Mar;20(3):491-500. doi: 10.1002/ejhf.1054. Epub 2017 Nov 22.

PMID:
29164797
32.

Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.

Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, Crespo-Leiro MG, Guazzi M, Harjola VP, Heymans S, Hill L, Lainscak M, Lam CSP, Lund LH, Lyon AR, Mebazaa A, Mueller C, Paulus WJ, Pieske B, Piepoli MF, Ruschitzka F, Rutten FH, Seferovic PM, Solomon SD, Shah SJ, Triposkiadis F, Wachter R, Tschöpe C, de Boer RA.

Eur J Heart Fail. 2018 Jan;20(1):16-37. doi: 10.1002/ejhf.1029. Epub 2017 Oct 16. Review.

33.

The role of atrial fibrillation in patients with an embolic stroke of unknown source (ESUS).

Wachter R, Freedman B.

Thromb Haemost. 2017 Oct 5;117(10):1833-1835. doi: 10.1160/TH17-08-0592. Epub 2017 Sep 14. No abstract available.

PMID:
28906543
34.

Relevance of supraventricular runs detected after cerebral ischemia.

Weber-Krüger M, Lutz C, Zapf A, Stahrenberg R, Seegers J, Witzenhausen J, Wasser K, Hasenfuß G, Gröschel K, Wachter R.

Neurology. 2017 Oct 10;89(15):1545-1552. doi: 10.1212/WNL.0000000000004487. Epub 2017 Sep 13.

PMID:
28904084
35.

Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study.

Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Wachter R, Pouliot E, Ziegler PD; REVEAL AF Investigators.

JAMA Cardiol. 2017 Oct 1;2(10):1120-1127. doi: 10.1001/jamacardio.2017.3180.

36.

Nucleotide Dependence of Subunit Rearrangements in Short-Form Rubisco Activase from Spinach.

Peterson-Forbrook DS, Hilton MT, Tichacek L, Henderson JN, Bui HQ, Wachter RM.

Biochemistry. 2017 Sep 12;56(36):4906-4921. doi: 10.1021/acs.biochem.7b00574. Epub 2017 Aug 25.

PMID:
28795566
37.

Heart failure awareness survey in Germany: general knowledge on heart failure remains poor.

Zelenak C, Radenovic S, Musial-Bright L, Tahirovic E, Sacirovic M, Lee CB, Jahandar-Lashki D, Inkrot S, Trippel TD, Busjahn A, Hashemi D, Wachter R, Pankuweit S, Störk S, Pieske B, Edelmann F, Düngen HD.

ESC Heart Fail. 2017 Aug;4(3):224-231. doi: 10.1002/ehf2.12144. Epub 2017 Mar 22.

38.

Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathy.

Callizo J, Feltgen N, Ammermann A, Ganser J, Bemme S, Bertelmann T, Pfeiffer S, Duvinage A, Gröschel K, Hoerauf H, Wachter R.

PLoS One. 2017 Aug 3;12(8):e0181766. doi: 10.1371/journal.pone.0181766. eCollection 2017.

39.

Atrial fibrillation in high-risk patients with ischaemic stroke - Authors' reply.

Wachter R, Gröschel K; Find-AF(RANDOMISED) Investigators and Coordinators.

Lancet Neurol. 2017 Jul;16(7):498. doi: 10.1016/S1474-4422(17)30165-5. Epub 2017 Jun 13. No abstract available.

PMID:
28653644
40.

Association between Embolic Stroke Patterns, ESUS Etiology, and New Diagnosis of Atrial Fibrillation: A Secondary Data Analysis of the Find-AF Trial.

Maier IL, Schregel K, Karch A, Weber-Krueger M, Mikolajczyk RT, Stahrenberg R, Gröschel K, Bähr M, Knauth M, Psychogios MN, Wachter R, Liman J.

Stroke Res Treat. 2017;2017:1391843. doi: 10.1155/2017/1391843. Epub 2017 Apr 27.

41.

Quantification of left atrial volume and phasic function using cardiovascular magnetic resonance imaging-comparison of biplane area-length method and Simpson's method.

Wandelt LK, Kowallick JT, Schuster A, Wachter R, Stümpfig T, Unterberg-Buchwald C, Steinmetz M, Ritter CO, Lotz J, Staab W.

Int J Cardiovasc Imaging. 2017 Nov;33(11):1761-1769. doi: 10.1007/s10554-017-1160-9. Epub 2017 May 18.

PMID:
28523471
42.

Exercise training in Diastolic Heart Failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial.

Edelmann F, Bobenko A, Gelbrich G, Hasenfuss G, Herrmann-Lingen C, Duvinage A, Schwarz S, Mende M, Prettin C, Trippel T, Lindhorst R, Morris D, Pieske-Kraigher E, Nolte K, Düngen HD, Wachter R, Halle M, Pieske B.

Eur J Heart Fail. 2017 Aug;19(8):1067-1074. doi: 10.1002/ejhf.862. Epub 2017 May 17. Review.

43.

Automatic detection of paroxysmal atrial fibrillation in patients with ischaemic stroke: better than routine diagnostic workup?

Uphaus T, Grings A, Gröschel S, Müller A, Weber-Krüger M, Wachter R, Gröschel K.

Eur J Neurol. 2017 Jul;24(7):990-994. doi: 10.1111/ene.13326. Epub 2017 May 15.

44.

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.

Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin LÅ, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP; AF-Screen Collaborators.

Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693. Review.

PMID:
28483832
45.

Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart Failure.

Lüers C, Edelmann F, Wachter R, Pieske B, Mende M, Angermann C, Ertl G, Düngen HD, Störk S.

Clin Cardiol. 2017 Sep;40(9):667-673. doi: 10.1002/clc.22710. Epub 2017 May 3.

46.

A peptide adhesive molded by magnesium glues Rubisco's subunits together.

Wachter RM.

J Biol Chem. 2017 Apr 21;292(16):6851-6852. doi: 10.1074/jbc.H116.767145.

47.

Arterial stiffness and elevated left ventricular filling pressure in patients at risk for the development or a previous diagnosis of HF-A subgroup analysis from the DIAST-CHF study.

Lüers C, Trippel TD, Seeländer S, Wachter R, Hasenfuss G, Lindhorst R, Bobenko A, Nolte K, Pieske B, Edelmann F.

J Am Soc Hypertens. 2017 May;11(5):303-313. doi: 10.1016/j.jash.2017.03.006. Epub 2017 Mar 27.

48.

Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function.

Wild PS, Felix JF, Schillert A, Teumer A, Chen MH, Leening MJG, Völker U, Großmann V, Brody JA, Irvin MR, Shah SJ, Pramana S, Lieb W, Schmidt R, Stanton AV, Malzahn D, Smith AV, Sundström J, Minelli C, Ruggiero D, Lyytikäinen LP, Tiller D, Smith JG, Monnereau C, Di Tullio MR, Musani SK, Morrison AC, Pers TH, Morley M, Kleber ME, Aragam J, Benjamin EJ, Bis JC, Bisping E, Broeckel U, Cheng S, Deckers JW, Del Greco M F, Edelmann F, Fornage M, Franke L, Friedrich N, Harris TB, Hofer E, Hofman A, Huang J, Hughes AD, Kähönen M, Investigators K, Kruppa J, Lackner KJ, Lannfelt L, Laskowski R, Launer LJ, Leosdottir M, Lin H, Lindgren CM, Loley C, MacRae CA, Mascalzoni D, Mayet J, Medenwald D, Morris AP, Müller C, Müller-Nurasyid M, Nappo S, Nilsson PM, Nuding S, Nutile T, Peters A, Pfeufer A, Pietzner D, Pramstaller PP, Raitakari OT, Rice KM, Rivadeneira F, Rotter JI, Ruohonen ST, Sacco RL, Samdarshi TE, Schmidt H, Sharp ASP, Shields DC, Sorice R, Sotoodehnia N, Stricker BH, Surendran P, Thom S, Töglhofer AM, Uitterlinden AG, Wachter R, Völzke H, Ziegler A, Münzel T, März W, Cappola TP, Hirschhorn JN, Mitchell GF, Smith NL, Fox ER, Dueker ND, Jaddoe VWV, Melander O, Russ M, Lehtimäki T, Ciullo M, Hicks AA, Lind L, Gudnason V, Pieske B, Barron AJ, Zweiker R, Schunkert H, Ingelsson E, Liu K, Arnett DK, Psaty BM, Blankenberg S, Larson MG, Felix SB, Franco OH, Zeller T, Vasan RS, Dörr M.

J Clin Invest. 2017 May 1;127(5):1798-1812. doi: 10.1172/JCI84840. Epub 2017 Apr 10.

49.

Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex-DHF pilot study.

Trippel TD, Holzendorf V, Halle M, Gelbrich G, Nolte K, Duvinage A, Schwarz S, Rutscher T, Wiora J, Wachter R, Herrmann-Lingen C, Duengen HD, Hasenfuß G, Pieske B, Edelmann F.

ESC Heart Fail. 2017 Feb;4(1):56-65. doi: 10.1002/ehf2.12109. Epub 2016 Aug 31.

50.

Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial.

Wachter R, Gröschel K, Gelbrich G, Hamann GF, Kermer P, Liman J, Seegers J, Wasser K, Schulte A, Jürries F, Messerschmid A, Behnke N, Gröschel S, Uphaus T, Grings A, Ibis T, Klimpe S, Wagner-Heck M, Arnold M, Protsenko E, Heuschmann PU, Conen D, Weber-Krüger M; Find-AF(randomised) Investigators and Coordinators.

Lancet Neurol. 2017 Apr;16(4):282-290. doi: 10.1016/S1474-4422(17)30002-9. Epub 2017 Feb 8. Erratum in: Lancet Neurol. 2017 Apr;16(4):261.

PMID:
28187920

Supplemental Content

Loading ...
Support Center